RecruitingNot ApplicableNCT05328856

Effects of Vital Shower on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being

An Randomised Controlled Trial on the Effects of Vital Shower (Hansgrohe) on Quality of Life, Immune Function, Cardiovascular Regulation and Well-being


Sponsor

Charite University, Berlin, Germany

Enrollment

50 participants

Start Date

May 25, 2022

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this exploratory randomized controlled clinical study is to evaluate the health-promoting effects of Kneipp hydrotherapy, in the form of the Vital Shower in a four-week daily application.


Eligibility

Min Age: 18 YearsMax Age: 70 Years

Inclusion Criteria1

  • Female and male patients between 18 and 70 years of age

Exclusion Criteria9

  • Bad general condition
  • Serious acute or chronic comorbidity
  • Pregnancy and breast feeding period/ in the next 6 months
  • Participation in a clinical trial within the last 3 months before enrollment
  • Simultaneous participation in another clinical trial
  • Raynaud's disease or cold agglutinin disease
  • Severe mental illness
  • Insufficiently treated dermatological diseases (e.g. neurodermatitis, psoriasis)
  • Non-compatible sanitary shower or bath devices

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DEVICEHansgrohe prototype/shower head

Start of the shower with warm comfort temperature and usual body cleansing. Then the Vital shower is carried out for a total of 3-5 minutes, followed optionally by another warm shower with 30 seconds or direct transition to a classic cold shower for 30- 60 seconds


Locations(1)

Charité Hochschulambulanz für Naturheilkunde am Immanuel Krankenhaus

Berlin, State of Berlin, Germany

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05328856


Related Trials